Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of the study is to determine whether vestibular and postural compensation following schwannoma surgery is improved by ablating vestibular function prior to surgery, even if vestibular function is absent according to modern assessment techniques
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2015
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2015
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedFirst Posted
Study publicly available on registry
April 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedSeptember 11, 2020
September 1, 2020
5.4 years
January 26, 2015
September 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences and changes of postural control following surgery, compared to before surgery
Postural control assessed with posturography during a sensory conflict
At first vestibular assessment at the time for inclusion and 6 months after surgery
Secondary Outcomes (12)
Occurrence of spontaneous nystagmus after surgery
Day 1 after surgery and for the duration of either spontaneous nystagmus or hospital stay (up to 2 weeks)
Change of hearing levels
At first vestibular assessment and 4weeks after gentamicin installation
Differences in the level of stress after surgery
Daily after surgery for the duration of the hospital stay, up to 2 weeks
Differences of subjective well being after surgery
Immediate time after surgery (2weeks)
Differences of duration of hospital stay
After surgery for the duration of the hospital stay up to 2 weeks
- +7 more secondary outcomes
Other Outcomes (1)
Differences of needed sick-leave from work and leisure activities
6 months after surgery
Study Arms (2)
Gentamicin treated
EXPERIMENTALInstallation of gentamicin in the middle ear 6 weeks prior to surgery + rehabilitation exercises before and after both treatment and surgery. Rehabilitation exercises are not considered to be an intervention since their benign impact on vestibular/postural compensation is well documented and exclusion from exercises would not be approved by the ethical board
Non-gentamicin
NO INTERVENTIONRehabilitation exercises before and after both treatment and surgery Rehabilitation exercises are not considered to be an intervention since their benign impact on vestibular/postural compensation is well documented and exclusion from exercises would not be approved by the ethical board
Interventions
Intratympanic installation of gentamicin 2-4 times depending on the efficacy of vestibular deafferentation
Eligibility Criteria
You may qualify if:
- Vestibular schwannoma advised to surgical treatment
- No measurable remaining vestibular function
You may not qualify if:
- impaired decision making
- neurofibromatosis
- signs for central dysfunction
- remaining vestibular function
- Patients are advised not to participate in the gentamicin arm if
- hearing is better than 30 deciBel (dB) in pure tone average (500, 1000, 2000, 3-4000 Hz) and speech discrimination better than 70%
- the neurosurgeon aim at hearing preservation surgery and do not want to risk gentamicin associated hearing loss
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lund Universitylead
Study Sites (1)
Dept. OtoRhinoLaryngology Head and Neck Surgery, Skane University Hospital
Lund, 22185, Sweden
Related Publications (6)
Parietti-Winkler C, Gauchard GC, Simon C, Perrin PP. Visual sensorial preference delays balance control compensation after vestibular schwannoma surgery. J Neurol Neurosurg Psychiatry. 2008 Nov;79(11):1287-94. doi: 10.1136/jnnp.2007.135913. Epub 2008 Aug 1.
PMID: 18676407BACKGROUNDMagnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Meniere's disease. Rationale for extremely low dose therapy. Acta Otolaryngol. 1991;111(4):671-6. doi: 10.3109/00016489109138398.
PMID: 1950529BACKGROUNDTjernstrom F, Fransson PA, Kahlon B, Karlberg M, Lindberg S, Siesjo P, Magnusson M. Vestibular PREHAB and gentamicin before schwannoma surgery may improve long-term postural function. J Neurol Neurosurg Psychiatry. 2009 Nov;80(11):1254-60. doi: 10.1136/jnnp.2008.170878. Epub 2009 Jul 1.
PMID: 19574236RESULTMagnusson M, Kahlon B, Karlberg M, Lindberg S, Siesjo P, Tjernstrom F. Vestibular "PREHAB". Ann N Y Acad Sci. 2009 May;1164:257-62. doi: 10.1111/j.1749-6632.2009.03778.x.
PMID: 19645909RESULTMagnusson M, Karlberg M, Tjernstrom F. 'PREHAB': Vestibular prehabilitation to ameliorate the effect of a sudden vestibular loss. NeuroRehabilitation. 2011;29(2):153-6. doi: 10.3233/NRE-2011-0689.
PMID: 22027076RESULTMagnusson M, Kahlon B, Karlberg M, Lindberg S, Siesjo P. Preoperative vestibular ablation with gentamicin and vestibular 'prehab' enhance postoperative recovery after surgery for pontine angle tumours--first report. Acta Otolaryngol. 2007 Dec;127(12):1236-40. doi: 10.1080/00016480701663433.
PMID: 17917842RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fredrik Tjernström, MD, PhD
Lund University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2015
First Posted
April 14, 2015
Study Start
April 1, 2015
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
September 11, 2020
Record last verified: 2020-09